MSK Rheumatology Flashcards
what is rheumatoid arthritis
mainstay of treatment
autoimmune condition that often affects the small joints (hands and feet) but can extend elsewhere and into other systems including cardiorespiratory
lifelong immunosuppression and sometimes surgery
what are the main deformations seen in rheumatoid arthritis
Z-thumb
Ulnar deviations
Boutonnaires
Swan neck finger deformities
how are T cells affected in autoimmunity
Regulatory T cells activity reduces
pathogenic T effector cells are upregulated
any part of the immune pathway dysregulated can cause autoimmunity
basics of immune response
dendritic cell presents antigens
T-helper cells (CD4+, MHC Class 2) release inflammatory interleukins and interferon and also activate humoral response (antibody mediated)
T-killer cells (CD8+, MHC Class 1) can also play a role
These processes all cause inflammation and tissue damage
T regulatory cells dampen the inflammation
differentiating between inflammatory and non inflammatory joint conditions
inflammatory such as RA tend to have morning stiffness that improves with activity
joint swelling is more indicative of inflammation with the exception of Nodal osteoarthritis and knee swelling which can be caused by trauma
non inflammatory such as OA tends to be pain more than stiffness and is exacerbated by activity
pattern/symmetry in RA
tends to be symmetrical and affects groups of joints e.g. all of the metacarpophalangeal joints
antibody tests useful in suspected connective tissue disorder
ANA
anti-DsDNA
antibody tests useful in suspected small/medium vessel vasculitis
ANCA
general management of inflammation in rheumatology
analgesia
anti-inflammatories
immunosuppression (steroids and biologics) - steroids are short term
Disease modifying drugs can also be used later (DMARDs)
protective treatment with steroids
in rheumatology always give bone protection with steroids from the start - vitamin D, calcium and bisphosphonates
gastroprotection also needed
names of DMARDs
azathioprine
methotrexate
hydroxychloriquine
sulfasalazine
lefunomide
azathioprine
inhibits DNA replication stopping proliferating cells
test for TPMT deficiency before as can cause toxicity
co-prescribing with allopurinol can cause toxicity
main adverse effect; bone marrow suppression –> pancytopenia and immunosuppression
methotrexate
dihydrofolate antagonist that targets proliferating cells
usually given once weekly and folic acid given on other days
folinic acid used as rescue therapy if OD
adverse effects; mouth ulcers, deranged LFTs, pneumonitis and bone marrow suppression
hydroxychloriquine adverse effects
photo sensitivity, retinal toxicity, haemolytic anaemia and bone marrow suppression
sulfasalazine adverse effects
haemolytic anaemia, azoospermia (avoid in young men), abnormal LFTs, bone marrow suppression
leflunomide adverse effects
alopecia, hypertension, pneumonitis, peripheral neuropathy, hepatotoxicity and bone marrow suppression
monoclonal antibodies in rheumatology
self injected or administered as infusions that can last for many weeks at a time
alternative to daily immunosuppressive medication but both are sometimes needed
only managed by specialists and need extensive screening before including blood tests, infection screens and ruling out latent TB
what is the common target of many monoclonal antibody medications
Tumour Necrosis Factor (TNF) - widespread immune mediator and a central role in inflammation
what do systemic symptoms e.g. weight loss, night sweats, reduced appetite suggest in a presentation of arthritis
more likely to be CTD/vaculitis/malignancy
symptoms to ask about to determine seronegative forms of arthritis
GI symptoms - IBD associated?
eye symptoms - iritis
psoriasis symptoms
what syndrome is commonly associated with rheumatoid arthritis
Sjrogen’s syndrome - ask about symptoms of dry eyes, dry mouth
what does boggy swelling indicate
suggests synovitis which occurs in inflammatory arthritis
in OA swelling is bony
what is the typical joint pattern in rheumatoid arthritis
inflammatory small joint polyarthritis affecting the hands, feet and wrists in a symmetrical distribution
in the hands tends to affect the metacarpophalangeal (MCP ) and proximal interphalangeal joints whereas in OA the distal interphalangeal joints are more likely to be affected
swan neck deformity (RA)
hyperextension of the PIPJ and flexion of the DIPJ
boutonnière deformity (RA)
flexion of the PIPJ and hyperextension of the DIPJ
guttering deformity (RA)
muscle wasting seen over the dorsum of the hand
management of suspected RA
analgesia and urgent referral to rheumatology
needs rapid and aggressive suppression of inflammation to reduce joint damage, maintain function and quality of life and prevent disability
investigations in suspected RA
- FBC, liver and renal function for baselines
- inflammatory markers
- thyroid function; can present with joint pain
- immune markers; rheumatoid factor and anti-CCP antibody may suggest rheumatoid arthritis, anti-nuclear antibody may indicate connective tissue disease
- plain film x-rays
anti-CCP compared to RF in diagnosing RA
anti-CCP is more specific and sensitive for RA
RF can be raised in other conditions including Sjrogen’s syndrome, other rheumatic conditions, malignancies and chronic infections
hand xray in RA
often normal in early disease
later may have periarticular osteopenia, erosions, joint space narrowing (usually uniform) and deformity
SoB in RA
respiratory conditions associated with RA including pulmonary fibrosis and pleural effusions can cause SoB. lung nodules also associated but wouldn’t cause SoB
consider concurrent conditions too; asthma, COPD, infection
criteria to diagnose RA
diagnostic criteria which covers joint involvement, serology, acute phase proteins and duration of symptoms
score of 6 or more needed
epidemiology RA/explanation
chronic autoimmune condition - immune system attacking own body causing inflammation in joints and can also affect other parts of the body
affects around 1 in 100 women and 1 in 200 men
needs long term treatment and often aggressive treatment to aim to control symptoms and prevent joint damage and disability
epidemiology RA/explanation
chronic autoimmune condition - immune system attacking own body causing inflammation in joints and can also affect other parts of the body
affects around 1 in 100 women and 1 in 200 men
needs long term treatment aim to control symptoms and prevent joint damage and disability
how is disease activity monitored in RA
Disease Activity Score (DAS 28) provides a score out of 10 and has categories of severity
uses:
- joint tenderness score
- number of joints
- patient global assessment (VAS out of 100)
- acute phase response (ESR/CRP)
how to check for swelling if synovitis not obvious on examination
USS - identifies swelling and bone erosions
treating active newly diagnosed rheumatoid arthritis
start a DMARD such as methotrexate, sulfasalazine, or leflunomide with pt education before
steroid therapy for symptom relief
extra-articular features in RA
- Scleritis and episcleritis
- dry eyes and dry mouth (esp Sjrogen’s)
- lymphadenopathy and splenomegaly
- vasculitis
- pericardial effusion and pleural effusion
- carpal tunnel
- palm and nail changes
- FBC changes; Normochromic normocytic anaemia; leukopenia; pancytopenia
- amyloidosis
- systemic symptoms; fatigue, weight loss, low grade fever
synovial changes in RA
- thickening and inflammation
- proliferative synovitis
- angiogenesis occurs –> more inflammatory cells infiltrate
- synovial fluid becomes fibrinous inflammatory exudate, containing many neutrophils
- local enzyme and mediator release can damage cartilage and cause bone erosion
treatment if doesn’t respond to initial DMARDs in RA
biologic therapy with a monoclonal antibody drug such as Rituximab or Tocilizumab or another biologic such as Abatacept and Baracitinib
joints affected by OA
weight bearing joints; cervical spine, lumbar spine, hip, knees, ankles
hands; wrist, DIP joints and PIP joints
what drug class increases risk of gout
diuretics especially thiazide
examination findings in OA
effusion
painful flexion
crepitus
weakness +/- muscle wasting
joint line tenderness
deformity
bony swelling
instability
antalgic gait
nodes in OA
Bouchard’s nodes - PIP joints
Heberdens’s nodes - DIP joints
any investigations needed to diagnose OA?
clinical diagnosis but consider
Bloods
- to rule out inflammatory arthritis
- U+Es to get baseline for diclofenac use
Xray affected joints
management of OA
- conservative
- pharmacological
- surgical
Conservative;
Patient education
Weightloss
Exercise/physiotherapy
Pharmacological;
Analgesia:
- topical anti-inflammatories/capaiscin cream
- WHO Ladder – paracetamol, NSAIDs (also COX2), opiods
Intra-articular steroid injection for moderate to severe pain
Surgical (joint replacement);
only if refractory to medical management and significant impact on life
OA pathophysiology
Dysregulation of tissue turnove
Focal articular cartilage damage leads to
- hypertrophy of subchondral bone
- marginal osteophytes
- synovitis
- thickening of joint capsule and ligaments
main modifiable risk factor in OA
other risk factors
obesity
increasing age
F>M
previous joint injury
intense sport activity
occupation
alignments and muscle strength
genetic factors
when to suspect secondary OA (due to another cause)
suspect in presentation <40 years, atypical joint distribution,
causes of secondary OA
Metabolic; crystal, Wilson’s, haemachromatosis, haemaglobinopathies, collagenopathies, acromegaly
Traumatic
Anatomical/congenital; slipped femoral epiphysis
epiphyseal dysplasia, congenital dislocated hip, unequal leg length, hyper mobility
neuropathic; syphilis, diabetes
inflammatory; septic or any other inflammatory A
steroid injections in OA
after topical anitinflammatories and analgesia
can have two injections in a joint if first worked but if severe after that consider joint replacement
differentials hot, painful, swollen joint
septic arthritis - must not miss
gout
psuedogout
haemarthrosis
psoriatic arthritis
reactive arthritis
gout risk factors
male
alcohol
high BMI
high purine intake - red meat, oily fish, marmite
other features of metabolic syndrome e.g. diabetes
investigations in an acutely hot, swollen joint
FBC and inflammatory markers - reactive/septic
Joint aspiration and synovial fluid analysis - gold standard for gout diagnosis
Blood cultures
Renal and Liver function
acute treatment of gout
fast acting NSAIDs such as Naproxen first line (coprescribe a PPI)
Colchicine if can’t have NSAIDs e.g in renal impairment
when and what prophylactic treatment should be used in gout
urate lowering therapy such as allopurinol which is lifelong
start when attacks are recurrent (>2 in 12 months) as can damage the joint, plus consider these factors:
- tophi
- joint damage
- renal impairment or Hx of kidney stones
- diuretic therapy
- gout starting at a young age
when after an attack should urate lowering therapy be started
2-4 weeks after an acute attack